NCT02018107View on ClinicalTrials.gov

PET/CT-Assessment of Liver Tumor Ablation

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 16, 2018

Study Completion Date

February 16, 2019

Conditions
Liver TumorLiver Neoplasms
Interventions
DIAGNOSTIC_TEST

N-13 ammonia or F-18 fluorodeoxyglucose

PET tracer

DIAGNOSTIC_TEST

PET scan

PET scan

Trial Locations (2)

02115

Brigham and Women's Hospital, Boston

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT02018107 - PET/CT-Assessment of Liver Tumor Ablation | Biotech Hunter | Biotech Hunter